Results 101 to 110 of about 198,351 (337)

Purpura fulminans [PDF]

JACEP Open, 2021
Florian Reizine, Lea Picard, Caroline Piau, Jean‐Marc Tadié   +3 more
openaire   +3 more sources

BMQ [PDF]

, 1963
BMQ: Boston Medical Quarterly was published from 1950-1966 by the Boston University School of Medicine and the Massachusetts Memorial ...
Antuna, Juan, Bagnoli, Thomas, Barber, Doris E., Cocchiarella, John P., Duke, Martin, Estes, J. Worth, Friedlander, Walter J., Goldsmith, Harry S., Gooding, Gretchen W., Goofman, Max L., Haseotes, Hytho V., Hass, Gerald, Hastings, A. Baird, Jackson, David R., Johnson, David S., Kechejian, Sarkis J., Kramer, Philip, Litman, George I., Madoff, Irving M., McLellan, Patricia A., O'Hara, Vincent S., Peabody, C. Newton, Pryles, Charles V., Small, Donald M., Tedeschi, Luke G., Walker, Sydney, III   +25 more
core  

Finasteride adverse effects and post-finasteride syndrome; implications for dentists [PDF]

, 2016
Finasteride is a 5α-reductase inhibitor widely used in present in the therapeutic approach of androgenic alopecia. Adverse effects consist in variable sign and symptoms, the most common being represented by mental troubles (reduced feeling of life ...
Dumitriu, Anca Silvia, Dumitriu, Horia Traian, Giurgiu, Marina, Motofei, Ion, Paunica, Ioana, Paunica, Stana, Vasilache, Adriana, Vasilache, Andrei   +7 more
core   +4 more sources

Complications at Diagnosis of Pediatric Chronic Myeloid Leukemia in Chronic Phase

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Chronic myeloid leukemia (CML) is uncommon during the first two decades of life, resulting in limited experience of pediatricians in handling this leukemia. This is even more true when it comes to managing rare complications at the time of diagnosis.
Nirmalya Roy Moulik, Uma Athale, Markus Metzler, Frederic Millot, Meinolf Suttorp   +4 more
wiley   +1 more source

Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis

BMC Pediatrics
Intravenous immunoglobulin (IVIg) is a first-line treatment for children with newly diagnosed immune thrombocytopenia (ITP). Higher doses of IVIg are associated with a more insupportable financial burden to pediatric patients’ families and may produce ...
Xiangge Ren, Miaomiao Zhang, Xiaohan Zhang, Peidong Zhao, Wensheng Zhai   +4 more
doaj   +1 more source

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

New England Journal of Medicine, 1991
BACKGROUND Thrombotic thrombocytopenic purpura is an uncommon disease with a high mortality rate even with current treatment. The cause of the syndrome and its optimal treatment are unknown.
G. Rock, K. Shumak, N. Buskard, V. Blanchette, J. Kelton, R. Nair, R. Spasoff   +6 more
semanticscholar   +1 more source

Eltrombopag for the treatment of immune thrombocytopenia: The aegean region of Turkey experience [PDF]

, 2015
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleeding complications may be mortal.
Alacacıoğlu, İ., Arslan, Ö., Bilgir, O., Bolaman, Z., Büyükkeçeci, F., Ceylan, C., Gökgöz, Z., Görgün, G., Kabukçu, Sibel, Kadıköylü, G., Kahraman, S., Keskin, A., Kiper, H.D., Payzın, B., Saydam, G., Sevindik, Ö.G., Tombuloğlu, M., Vural, F., Çağlıyan, G.A., Özcan, M.A., Özdemirkıran, F., Şahin, F.   +21 more
core   +4 more sources

Population Pharmacokinetics and Exposure‐Response Relationship of Hemoporfin in Pediatric Patients With Port‐Wine Stain

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Hemoporfin, a porphyrin derivative photosensitizer, has been approved for the treatment of port‐wine stain (PWS) in adults. However, its optimal dose for the pediatric population remains unclear. This study aimed to explore appropriate dosing for pediatric patients with PWS through population pharmacokinetics (PopPK) and exposure‐response (ER)
Rong Chen, Bin Zhang, Jining Tao, Qingyu Yao, Tianyan Zhou, Lin Ma, Zigang Xu   +6 more
wiley   +1 more source

Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis

PLoS ONE, 2016
Background and objective Henoch-Schönlein purpura (HSP) is an important cause of chronic kidney disease in children. This meta-analysis identified risk factors associated with renal involvement in childhood HSP. Methods PubMed, Embase, and Web of Science
Han Chan, Yangzhang Tang, Xiaoyan Lv, Gaofeng Zhang, Mo Wang, Haiping Yang, Qiu Li   +6 more
semanticscholar   +1 more source

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura : A Single Technology Appraisal [PDF]

, 2008
Evidence Review Group (ERG) final report for the National Institute for Health and Clinical ExcellencePublisher ...
Boyers, Dwayne, Crowther, M, Fraser, Cynthia Mary, Jenkinson, David James, Jia, Xueli, Mowatt, Graham   +5 more
core